Japan Accelerates Regenerative Medicine & Cell Therapy Startups via JEAP Program | Advanced Therapy Medicinal Product Market 2025

Advanced Therapy Medicinal Product Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

The Advanced Therapy Medicinal Product Market takes center stage in DataM Intelligence's latest in-depth analysis, where expert researchers apply advanced analytics and strategic foresight to deliver unmatched market intelligence. This comprehensive report offers a detailed examination of the competitive landscape, highlighting key players and their innovations in product development, pricing models, financial performance, and global expansion strategies. By uncovering the driving forces, market dynamics, and disruptive trends shaping the industry's future, the study equips stakeholders with actionable insights to navigate an increasingly dynamic and competitive environment.

📌 Download your Sample Report Instantly - Corporate Email ID required for priority access:- https://www.datamintelligence.com/download-sample/advanced-therapy-medicinal-product-atmp-market?rk

Recent Developments:

United States: Recent Industry Developments

✅ In May 2025, Minaris Advanced Therapies was launched as a global partner dedicated to cell therapy development, manufacturing, and testing, following the merger of Minaris Regenerative Medicine and WuXi Advanced Therapies operations in the U.S. and U.K.

✅ In July 2025, the global advanced therapy medicinal products CDMO market size increased from USD 6.73 billion in 2024 to USD 7.99 billion in 2025, with projections to reach around USD 37.27 billion by 2034, expanding at a CAGR of 18.82% between 2025 and 2034.

✅ In May 2025, AstraZeneca announced the acquisition of the biotechnology company EsoBiotec for up to $1 billion, aiming to expand its investments in cell therapies for cancer treatment.

Japan: Recent Industry Developments

✅ In September 2025, the Japan Entry Acceleration Program (JEAP) opened applications for regenerative medicine/cell and gene therapy startups, offering tailored mentorship, market insights, and connections with leading CDMOs/CROs and pharmaceutical companies to accelerate entry, collaboration, and growth in Japan's healthcare market.

✅ In July 2025, Japan's pharmaceutical regulatory landscape underwent significant transformation, driven by efforts to reduce Japan's drug lag, enhance clinical trial systems, modernize post-approval processes, and support innovative therapies.

✅ In May 2025, Takeda Pharmaceutical confirmed three pivotal Phase III clinical trial readouts scheduled for 2025, marking critical milestones in their late-stage pipeline development.

☛ Advanced Therapy Medicinal Product Market Dynamics and Drivers

The Advanced Therapy Medicinal Product (ATMP) market is witnessing rapid growth due to the rising prevalence of genetic disorders, chronic diseases, and cancers that require innovative treatment approaches. ATMPs, which include gene therapies, somatic-cell therapies, and tissue-engineered products, offer highly targeted and potentially curative solutions, driving their adoption in both clinical and research settings. Increasing regulatory support and fast-track approvals for breakthrough therapies are further accelerating market expansion.

Technological advancements in gene editing, cell therapy manufacturing, and delivery systems are improving efficacy, safety, and scalability of ATMPs. Collaborations between biopharmaceutical companies, research institutions, and contract development organizations are boosting innovation and reducing time-to-market. Growing investments in R&D, rising healthcare expenditure, and the expansion of personalized medicine initiatives are expected to continue fueling the global ATMP market over the coming years.

☛ Advanced Therapy Medicinal Product Market Competitive Landscape:

RHEACELL., BioTissue Technologies GmbH, Mukocell GmbH, Orchard Therapeutics plc., Kite Pharma EU B.V., Bristol-Myers Squibb Pharma EEIG, Novartis Europharm Limited, and Amgen Europe B.V.

Research Methodology

We employ a hybrid approach, integrating qualitative insights with robust quantitative analysis to deliver comprehensive and reliable market intelligence. The process starts with extensive secondary research, leveraging trusted industry publications, proprietary databases, and credible market sources. This foundation is then strengthened through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/advanced-therapy-medicinal-product-atmp-market

☛ Segment Covered in the Advanced Therapy Medicinal Product Market:

By Type (Gene Therapy Medicines, Somatic Cell Therapy Medicines, Tissue Engineered Medicines)

By Disease Indication (Cancer, Cardiovascular diseases, Musculoskeletal, Immune System and Inflammation, Neurology, Others)

☛ This Report Covers:

✔ Comprehensive go-to-market strategy insights.

✔ An unbiased evaluation of market performance.

✔ In-depth analysis of development trends, competitive landscape, supply and demand dynamics, year-on-year growth, competitive benchmarking, vendor mapping, market access, and overall development status.

✔ Customized regional and country-level reports available on request, including detailed localized analysis.

✔ Identification of potential and niche segments/regions showcasing strong growth opportunities.

✔ Application of both top-down and bottom-up approaches for accurate regional market analysis.



📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=advanced-therapy-medicinal-product-atmp-market

☛ Regional Analysis for Advanced Therapy Medicinal Product Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Advanced Therapy Medicinal Product Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Advanced Therapy Medicinal Product Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Advanced Therapy Medicinal Product Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.